Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 19.94
-0.23 (-1.14%)
Sep 9, 2026, 4:00 PM EDT
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 10.13 billion as of September 9, 2026. Its market cap has decreased by -35.99% in one year.
Market Cap
10.13B
Enterprise Value
9.95B
Revenue
648.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.94
ChartMarket Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 10.13B, an increase of 22.69%. That is a compound annual growth rate of 4.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 10.13B | -17.46% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang CONBA Pharmaceutical | 11.32B |
| Beijing Aosaikang Pharmaceutical | 11.29B |
| Porton Pharma Solutions | 11.23B |
| Henan Lingrui Pharmaceutical | 11.08B |
| Shenzhen Chipscreen Biosciences | 11.03B |
| Yantai Dongcheng Pharmaceutical Group | 10.40B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 10.21B |
| PharmaBlock Sciences (Nanjing) | 10.21B |